The Social Community forBiohackers Connect

Biology is complicated. Perhaps see on your next retest; could be delayed, an outlier result, a genuinely bad test, or something changed that you’re not considering.

Speaking of coffee I’ve been LOVING Praxanthine. It’s a downstream metabolite of caffeine that is far less habit-forming, tolerance-building, and the best part — half-life is only about 3 hours, so it does not affect #Sleep at all. Also, no jitters and far less anxiety-inducing. I’ve been taking about 200mg first thing in the morning and then about 160mg at about 1pm. I still drink decaf coffee all day. It’s so good I can’t believe it’s not way more popular. #Biohackers Connect https://en.wikipedia.org/wiki/Paraxanthine

I don't think you have as much control over how your kids turn out as you think

Oura, the maker of a popular ring that tracks people’s health, said Tuesday it was postponing its initial public offering, “despite strong demand, due to uncertainty in the IPO market.” Oura was scheduled to go public later this week. The company had made public its IPO filing at the beginning of this month and last week it had disclosed its tentative pricing, making clear it wanted to take the company public at a premium valuation. (https://e.customeriomail.com/e/c/eyJlbWFpbF9pZCI6ImRnU2kwUVlDQUplSkJwYUpCZ0dnOGZpd3FhZzFMLXNWRVdmRm9XND0iLCJocmVmIjoiaHR0cHM6Ly93d3cudGhlaW5mb3JtYXRpb24uY29tL25ld3NsZXR0ZXJzL3RoZS1icmllZmluZy9vdXJhLW1heS1oZWFsdGhpZXN0LWlwbz9yYz05Ynl4cmlcdTAwMjZ1dG1fY2FtcGFpZ249JTVCUkVCUkFORCU1RCslNUJUSS1BTSU1RCtUaFx1MDAyNnV0bV9jb250ZW50PTEwOTVcdTAwMjZ1dG1fbWVkaXVtPWVtYWlsXHUwMDI2dXRtX3NvdXJjZT1jaW9cdTAwMjZ1dG1fdGVybT0xMjQiLCJpbnRlcm5hbCI6ImEyZDEwNjAzODY0YTk3ODkwNiJ9/53452ec554a295a00f3afbc18ba091dc74884d6682f0405e3a9147d4794fbd9c) But the company faced some skepticism. One analyst, Arete Research’s Richard Kramer, likened Oura to other “single product plus subscription models that didn’t end well,” such as Peloton, GoPro and Fitbit. Moreover, wariness is spreading among investors about AI financing, possibly influencing Oura’s thinking. Oura isn’t under pressure to go public, as the company makes money and nearly all the money the company would have raised from the offering would go to satisfy tax payments related to employee stock awards.

Turning this into a collaborative "Team Human" effort is actually a great move. Science has always been about collective problem-solving, so testing how human intuition works alongside AI agents gives a much clearer picture of how real breakthroughs will happen.

Nica took a screenshot of this post and discussion · 3 weeks ago

Why this is a big deal: this mRNA therapy instructs the body to produce the specific fingerprints of the person's tumor and trains the immune system to hunt and kill it. First time in a Phase 3 trial. One way cancer grows is by hiding from the immune system and turning off attacking T-cells. This mRNA therapy provides the tumor's genetic fingerprint so that the immune system can train T-cells to identify the cancer. Keytruda then removes the brakes that cancer had put on the T-cells enabling them to eliminate the cancer.

Big fan. Last I bought the powder from Everychem, but there are a couple of brands on Amazon also.

replace protein with peptides and it me